Sljedeći

Auto Play

Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

6 Pogledi • 07/30/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play